glp-1 controversy Government advisory on weight-loss drugs is a step forward, but is it enough? How will it curb misuse? I break down the key concerns on Health360, #Health360 #health360plus , Credit @indiatoday cms/asset/5780f2cd-5e61-47ad-b5f8-a85...

The peptide vial research article explains what to look for when evaluating vial quality

Those findings raised concerns about skin cancer risks that regulators were unwilling to overlook

Lancet 2008;371:117-25.ArticlePubMed 650

Using insights from our podcast series, Beyond the Scale: The Ozempic Effect , Drugwatch examines the complexities of insurance coverage, the role of health care providers and the risks of off-label use

After mcl transaction bpc 157 was effective in rats when given once daily intraperitoneally (10 microg or 10 ng/kg) or locally as a thin layer (1.0 microg dissolved in distilled water/g commercial neutral cream) at the site of injury, first application 30 min after surgery and the final application 24 h before sacrifice